x

Posted 25 August, 2021

China Botanic Pharmaceutical appointed new CEO

CEO Change detected for ticker OTC:FBDS in a 8-K filed on 25 August, 2021.


  Accordingly, David Lazar, serving as a director and an officer, ceased to be the Company's Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of China Botanic Pharmaceutical
Health Care/Life Sciences • Pharmaceuticals
Fuss Brands Corp. engages in the research, manufacture and distribution of botanical products, bio-pharmaceutical products, and traditional Chinese medicines. Its products include Siberian ginseng, other plant-based anti-depression and nerve regulation products, botanical antibiotics, badger oil, and ginseng and deer antler extracts. The company was founded on August 18, 1988 and is headquartered in New York, NY.
Market Cap
N/A
View Company Details
China Botanic Pharmaceutical by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On August 24, 2021, the existing director and officer resigned immediately. Accordingly, David Lazar, serving as a director and an officer, ceased to be the Company's Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director. At the effective date of the transfer, Issamar Ginzberg consented to act as the new Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director of the Company,


Issamar Ginzberg, Chairman/CEO - Mr. Ginzberg is a serial entrepreneur who has assisted entrepreneurs and organizations, consulting on business strategy and marketing insights. In 2005, Mr. Ginzberg began his own consulting business specializing in the field of strategic marketing for emerging companies. In 2012, Issamar founded Monetized Intellect Consulting to assist companies with advice and strategy for communicating their offerings and vision with their current and potential customers and stakeholders. Since 2013, Mr. Ginzberg has been CEO of It's All From Above, LLC, a consulting firm which has advised hundreds of companies across the world to improve their business strategy, processes, and marketing and grow their brands. Services include copywriting, brand creation, advisory services on M&A, and business strategy.


Aside from his normal business activities, Issamar serves in advisory role to several companies including Marx Bio and Shtar. Additionally, Mr. Ginzberg is often called upon to give marketing lectures at various companies (i.e. Google, Tel Aviv University and the Jewish National Fund). Mr. Ginzberg has authored or been interviewed for many articles that have been featured in various publications including The Washington Post, Prevention Magazine, The Jerusalem Post, CNBC and Fox Business.